Serology of lupus erythematosus: Correlation between immunopathological features and clinical aspects

Autoimmune Diseases

Volumn 2014, Issue , 2014, Pages

  Cozzani, Emanuele ^a   Drosera, Massimo ^a   Gasparini, Giulia ^a   Parodi, Aurora ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C1Q ANTIBODY; CYCLINE; DOUBLE STRANDED DNA ANTIBODY; HISTONE ANTIBODY; LA ANTIBODY; NUCLEOSOME ANTIBODY; PHOSPHOLIPID ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RIBOSOMAL P ANTIBODY; RO ANTIBODY; SM ANTIBODY; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; IMMUNOPATHOLOGY; LUPUS LIKE SYNDROME; NEUROPSYCHIATRY; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84896877785     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2014/321359     Document Type: Review

References (128)

1. Sherer Y., Gorstein A., Fritzler M. J., Shoenfeld Y., Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Seminars in Arthritis and Rheumatism 2004 34 2 501 537 2-s2.0-14244250736 10.1016/j.semarthrit.2004.07.002
2. Hargraves M., Richmond H., Morton R., Presentation of two bone marrow components, the tart cell and the LE cell. Mayo Clinic Proceedings 1948 21 25 28
3. Ceppellini R., Polli E., Celada F., A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proceedings of the Society for Experimental Biology and Medicine 1957 96 3 572 574 2-s2.0-0000373624
4. Tan E. M., Kunkel H. G., Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. Journal of Immunology 1966 96 3 464 471 2-s2.0-0013886630
5. Rekvig O. P., Putterman C., Casu C., Gao H.-X., Ghirardello A., Mortensen E. S., Tincani A., Doria A., Autoantibodies in lupus: culprits or passive bystanders? Autoimmunity Reviews 2012 11 8 596 603 2-s2.0-80755130320 10.1016/j.autrev.2011.10.021
6. Gualtierotti R., Biggioggero M., Penatti A. E., Meroni P. L., Updating on the pathogenesis of systemic lupus erythematosus. Autoimmunity Reviews 2010 10 1 3 7 2-s2.0-78149357662 10.1016/j.autrev.2010.09.007
7. Diamond B., Bloom O., Al Abed Y., Kowal C., Huerta P. T., Volpe B. T., Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus. Journal of Internal Medicine 2011 269 1 36 44 2-s2.0-78650221829 10.1111/j.1365-2796.2010.02318.x
8. Wittemann B., Neuer G., Michels H., Truckenbrodt H., Bautz F. A., Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis. Arthritis & Rheumatism 1990 33 9 1378 1383 2-s2.0-0025008371
9. Abdulahad D. A., Westra J., Bijzet J., Limburg P. C., Kallenberg C. G. M., Bijl M., High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Research & Therapy 2011 13 3, article R71 2-s2.0-79955675740 10.1186/ar3332
10. Schierbeck H., Lundbäck P., Palmblad K., Klevenvall L., Erlandsson-Harris H., Andersson U., Ottosson L., Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models. Molecular Medicine 2011 17 9-10 1039 1044 2-s2.0-84858764021
11. Pisetsky D. S., Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification. Scandinavian Journal of Immunology 2012 76 3 223 228
12. Fauci A., Kasper D., Longo D., Braunwald E., Hauser S., Jameson J. L., Harrison's Principles of Internal Medicine 2008 17th McGraw-Hill
13. Hochberg M. C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism 1997 40 9 1725 2-s2.0-0031229830
14. Bizzaro N., Villalta D., Giavarina D., Tozzoli R., Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmunity Reviews 2012 12 2 97 106
15. Ghirardello A., Caponi L., Franceschini F., Zampieri S., Quinzanini M., Bendo R., Bombardieri S., Gambari P. F., Doria A., Diagnostic tests for antiribosomal P protein antibodies: a comparative evaluation of immunoblotting and ELISA assays. The Journal of Autoimmunity 2002 19 1-2 71 77 2-s2.0-0036700344 10.1006/jaut.2002.0595
16. Doria A., Zen M., Canova M., Bettio S., Bassi N., Nalotto L., Rampudda M., Ghirardello A., Iaccarino L., SLE diagnosis and treatment: when early is early. Autoimmunity Reviews 2010 10 1 55 60 2-s2.0-78149359043 10.1016/j.autrev.2010.08.014
17. Hanly J. G., Urowitz M. B., Siannis F., Farewell V., Gordon C., Bae S. C., Isenberg D., Dooley M. A., Clarke A., Bernatsky S., Gladman D., Fortin P. R., Manzi S., Steinsson K., Bruce I. N., Ginzler E., Aranow C., Wallace D. J., Ramsey-Goldman R., Van Vollenhoven R., Sturfelt G., Nived O., Sanchez-Guerrero J., Alarcón G. S., Petri M., Khamashta M., Zoma A., Font J., Kalunian K., Douglas J., Qi Q., Thompson K., Merrill J. T., Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis & Rheumatism 2012 64 8 2677 2686
18. Shivastava A., Khanna D., Autoantibodies in systemic lupus erythematosus: revisited. Indian Journal of Rheumatology 2011 6 3 138 142 2-s2.0-80053535984 10.1016/S0973-3698(11)60076-9
19. To C. H., Petri M., Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis & Rheumatism 2005 52 12 4003 4010 2-s2.0-29144445982 10.1002/art.21414
20. Ching K. H., Burbelo P. D., Tipton C., Wei C., Petri M., Sanz I., Iadarola M. J., Two major autoantibody clusters in systemic lupus erythematosus. PLoS ONE 2012 7 2 2-s2.0-84857420334 10.1371/journal.pone.0032001 e32001
21. Marks S. D., Tullus K., Autoantibodies in systemic lupus erythematosus. Pediatric Nephrology 2012 27 10 1855 1868
22. Wiik A. S., Høier-Madsen M., Forslid J., Charles P., Meyrowitsch J., Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. The Journal of Autoimmunity 2010 35 3 276 290 2-s2.0-77957820978 10.1016/j.jaut.2010.06.019
23. Arinuma Y., Yanagida T., Hirohata S., Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis & Rheumatism 2008 58 4 1130 1135 2-s2.0-42449089701 10.1002/art.23399
24. Hansen K. E., Arnason J., Bridges A. J., Autoantibodies and common viral illnesses. Seminars in Arthritis and Rheumatism 1998 27 5 263 271 2-s2.0-0031926079 10.1016/S0049-0172(98)80047-4
25. Isenberg D. A., Manson J. J., Ehrenstein M. R., Rahman A., Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology 2007 46 7 1052 1056 2-s2.0-34447320202 10.1093/rheumatology/kem112
26. Maya R., Gershwin M. E., Shoenfeld Y., Hepatitis B virus (HBV) and autoimmune disease. Clinical Reviews in Allergy and Immunology 2008 34 1 85 102 2-s2.0-49349090729 10.1007/s12016-007-8013-6
27. Zieve G. W., Khusial P. R., The anti-Sm immune response in autoimmunity and cell biology. Autoimmunity Reviews 2003 2 5 235 240 2-s2.0-0041761208 10.1016/S1568-9972(03)00018-1
28. Pagana K. D., Pagana T. J., Mosby's Diagnostic and Laboratory Test Reference 2013 9th
29. Bruns A., Bläss S., Hausdorf G., Burmester G. R., Hiepe F., Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis & Rheumatism 2000 43 10 2307 2315
30. Quattrocchi P., Barrile A., Bonanno D., Giannetto L., Patafi M., Tigano V., Ferlazzo B., The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases. Reumatismo 2005 57 2 109 113 2-s2.0-27644557437
31. Rubin R. L., Burlingame R. W., Arnott J. E., Totoritis M. C., McNally E. M., Johnson A. D., IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus. Journal of Immunology 1995 154 5 2483 2493 2-s2.0-0028928935
32. Salazar-Paramo M., Rubin R. L., Garcia-De La Torre I., Systemic lupus erythematosus induced by isoniazid. Annals of the Rheumatic Diseases 1992 51 9 1085 1087 2-s2.0-0026701169
33. Eriksson C., Kokkonen H., Johansson M., Hallmans G., Wadell G., Rantapää-Dahlqvist S., Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Research & Therapy 2011 13 1, article R30 2-s2.0-79951800941 10.1186/ar3258
34. Chan E. K. L., Hamel J. C., Buyon J. P., Tan E. M., Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. The Journal of Clinical Investigation 1991 87 1 68 76 2-s2.0-0026082028
35. Yoshimi R., Ueda A., Ozato K., Ishigatsubo Y., Clinical and pathological roles of Ro/SSA autoantibody system. Clinical and Developmental Immunology 2012 2012 12 606195 10.1155/2012/606195
36. Rivera T. L., Izmirly P. M., Birnbaum B. K., Byrne P., Brauth J. B., Katholi M., Kim M. Y., Fischer J., Clancy R. M., Buyon J. P., Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. Annals of the Rheumatic Diseases 2009 68 6 828 835 2-s2.0-67449133557 10.1136/ard.2008.088054
37. Ghirardello A., Doria A., Zampieri S., Gambari P. F., Todesco S., Autoantibodies to ribosomal P proteins in systemic lupus erythematosus. Israel Medical Association Journal 2001 3 11 854 857 2-s2.0-0035691673
38. Hanly J. G., Urowitz M. B., Siannis F., Farewell V., Gordon C., Bae S. C., Isenberg D., Dooley M. A., Clarke A., Bernatsky S., Gladman D., Fortin P. R., Manzi S., Steinsson K., Bruce I. N., Ginzler E., Aranow C., Wallace D. J., Ramsey-Goldman R., Van Vollenhoven R., Sturfelt G., Nived O., Sanchez-Guerrero J., Alarcón G. S., Petri M., Khamashta M., Zoma A., Font J., Kalunian K., Douglas J., Qi Q., Thompson K., Merrill J. T., Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis & Rheumatism 2008 58 3 843 853 2-s2.0-40549134936 10.1002/art.23218
39. Chu P., Pendry K., Blecher T. E., Detection of lupus anticoagulant in patients attending an anticoagulation clinic. British Medical Journal 1988 297 6661 1449 2-s2.0-0024242521
40. Hegazy A., Barakat A. F., Gayyar M. A. E., Arafa L. F., Prevalence and clinical significance of anti-C1q antibodies in cutaneous and systemic lupus erythematosus. The Egyptian Journal of Medical Human Genetics 2012 13 167 171
41. Wener M. H., Mannik M., Schwartz M. M., Lewis E. J., Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine 1987 66 2 85 97 2-s2.0-0023255363
42. Williamson G. C., Pennebaker J., Boyle J. A., Clinical characteristics of patients with rheumatic disorders who possess antibodies against ribonucleoprotein particles. Arthritis & Rheumatology 1983 26 4 509 515
43. Williamson G. C., Mary A., Snyder L. M., Wallach J. B., Autoimmune and miscellaneous diseases. Wallach's Interpretation of Diagnostic Tests 2011 Philadelphia, Pa, USA Wolters Kluwer, Lippincott Williams & Wilkins 1035
44. Wenzel J., Bauer R., Bieber T., Böhm I., Autoantibodies in patients with lupus erythematosus: spectrum and frequencies. Dermatology 2000 201 3 282 283 2-s2.0-0033679374
45. Hsu T.-C., Tsay G. J., Chen T.-Y., Liu Y.-C., Tzang B.-S., Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection. Clinical & Experimental Immunology 2006 144 1 110 116 2-s2.0-33645107578 10.1111/j.1365-2249.2006.03046.x
46. Hanly J. G., Su L., Farewell V., Fritzler M. J., Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. Journal of Immunological Methods 2010 358 1-2 75 80 2-s2.0-77953291702 10.1016/j.jim.2010.04.005
47. Bardin N., Desplat-Jego S., Daniel L., Jourde Chiche N., Sanmarco M., BioPlexe 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Autoimmunity 2009 42 1 63 68 2-s2.0-58149485195 10.1080/08916930802354906
48. Hanly J. G., Thompson K., McCurdy G., Fougere L., Theriault C., Wilton K., Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. Journal of Immunological Methods 2010 352 1-2 147 152 2-s2.0-71849102119 10.1016/j.jim.2009.10.003
49. James W. D., Berger T. G., Elston D. M., Andrews' Diseases of the Skin. Clinical Dermatology 2011 11th Saunders Elsevier
50. Solomon D. H., Kavanaugh A. J., Schur P. H., Solomon D. H., Schur P., Kavanaugh A. F., Reveille J. D., Sherrer Y. R. S., Lahita R., Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis & Rheumatism 2002 47 4 434 444 2-s2.0-0037103187
51. Bizzaro N., Wiik A., Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clinical and Experimental Rheumatology 2004 22 3 349 355 2-s2.0-2342539777
52. Bonfa E., Golombek S. J., Kaufman L. D., Association between lupus psychosis and anti-ribosomal P protein antibodies. The New England Journal of Medicine 1987 317 5 265 271 2-s2.0-0023177710
53. Ippolito A., Wallace D. J., Gladman D., Fortin P. R., Urowitz M., Werth V., Costner M., Gordon C., Alarcón G. S., Ramsey-Goldman R., Maddison P., Clarke A., Bernatsky S., Manzi S., Bae S.-C., Merrill J. T., Ginzler E., Hanly J. G., Nived O., Sturfelt G., Sanchez-Guerrero J., Bruce I., Aranow C., Isenberg D., Zoma A., Magder L. S., Buyon J., Kalunian K., Dooley M. A., Steinsson K., Van Vollenhoven R. F., Stoll T., Weisman M., Petri M., Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus 2011 20 3 250 255 2-s2.0-79958255101 10.1177/ 0961203310385738
54. Hahn B. H., Antibodies to DNA. The New England Journal of Medicine 1998 338 19 1359 1368 2-s2.0-0032493059 10.1056/NEJM199805073381906
55. Teodorescu M., Clinical value of anti-ssDNA (denatured DNA) autoantibody test: beauty is in the eyes of the beholder. Clinical and Applied Immunology Reviews 2002 2 2 115 128 2-s2.0-0036555797 10.1016/S1529-1049(01)00042-3
56. Reveille J. D., Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 2004 13 5 290 297 2-s2.0-2942726299 10.1191/0961203303lu1015oa
57. Yu C.-L., Huang M.-H., Tsai C.-Y., Sun K.-H., Hsieh S.-C., Tsai Y.-Y., Tsai S.-T., Yu H.-S., Han S.-H., The reactivity of sera from patients with systemic lupus erythematosus to seven different species of single and double stranded deoxyribonucleic acids. Clinical and Experimental Rheumatology 1996 14 2 137 144 2-s2.0-0029951094
58. Albani S., Massa M., Viola S., Pellegrini G., Martini A., Antibody reactivity against single stranded DNA of various species in normal children and in children with diffuse connective tissue diseases. Autoimmunity 1990 8 1 77 80 2-s2.0-0025636425
59. Misra R., Malaviya A. N., Kumar R., Kumar A., Clinical relevance of the estimation of antibodies to single stranded DNA in systemic lupus erythematosus. The Indian Journal of Medical Research 1988 87 463 467 2-s2.0-0024006556
60. Koffler D., Agnello V., Winchester R., Kunkel H. G., The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. The Journal of Clinical Investigation 1973 52 1 198 204 2-s2.0-0015535196
61. Bootsma H., Spronk P., Derksen R., De Boer G., Wolters-Dicke H., Hermans J., Limburg P., Gmelig-Meyling F., Kater L., Kallenberg C., Prevention of relapses in systemic lupus erythematosus. The Lancet 1995 345 8965 1595 1599 2-s2.0-0029020939 10.1016/S0140-6736(95)90114-0
62. Yung S., Chan T. M., Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown. Clinical and Developmental Immunology 2012 2012 13 139365 10.1155/2012/139365
63. Shoenfeld Y., Toubi E., Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. Arthritis & Rheumatism 2005 52 9 2599 2606 2-s2.0-25444485683 10.1002/art.21252
64. Witte T., IgM antibodies against dsDNA in SLE. Clinical Reviews in Allergy and Immunology 2008 34 3 345 347 2-s2.0-49349092339 10.1007/s12016-007- 8046-x
65. Husebye E. S., Sthoeger Z. M., Dayan M., Zinger H., Elbirt D., Levite M., Mozes E., Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases 2005 64 8 1210 1213 2-s2.0-23444443656 10.1136/ard.2004.029280
66. Yoshio T., Onda K., Nara H., Minota S., Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis & Rheumatism 2006 54 2 675 678 2-s2.0-32444447026 10.1002/art.21547
67. Hanly J. G., Robichaud J., Fisk J. D., Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. Journal of Rheumatology 2006 33 8 1553 1558 2-s2.0-33746683740
68. Franchin G., Son M., Kim S. J., Ben-Zvi I., Zhang J., Diamond B., Anti-DNA antibodies cross-react with C1q. The Journal of Autoimmunity 2013 44 34 39
69. ter Borg E. J., Horst G., Limburg P. C., Kallenberg C. G. M., Shifts of anti-Sm-specific antibodies in patients with systemic lupus erythematosus: analysis by counter-immunoelectrophoresis, immunoblotting and RNA-immunoprecipitation. The Journal of Autoimmunity 1991 4 1 155 164 2-s2.0-0025973379 10.1016/0896-8411(91)90014-4
70. Habets W. J., de Rooij D. J., Hoet M. H., van de Putte L. B., van Venrooij W. J., Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clinical & Experimental Immunology 1985 59 2 457 466 2-s2.0-0021972755
71. Amoura Z., Chabre H., Bach J. F., Koutouzov S., Antinucleosome antibodies and systemic lupus erythematosus. Advances in Nephrology from the Necker Hospital 1997 26 303 316 2-s2.0-0030638959
72. van der Vlag J., Berden J. H. M., Lupus nephritis: role of antinucleosome antibodies. Seminars in Nephrology 2011 31 4 376 389 2-s2.0-79961212382 10.1016/j.semnephrol.2011.06.009
73. Ullal A. J., Reich C. F. III, Clowse M., Criscione-Schreiber L. G., Tochacek M., Monestier M., Pisetsky D. S., Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. The Journal of Autoimmunity 2011 36 3-4 173 180 2-s2.0-79954950134 10.1016/j.jaut.2011.02.001
74. Saisoong S., Eiam-Ong S., Hanvivatvong O., Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients. Clinical and Experimental Rheumatology 2006 24 1 51 58 2-s2.0-33645084540
75. Amoura Z., Piette J. C., Bach J. F., Koutouzov S., The key role of nucleosomes in lupus. Arthritis & Rheumatism 1999 42 833 843
76. Burlingame R. W., Boey M. L., Starkebaum G., Rubin R. L., The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. The Journal of Clinical Investigation 1994 94 1 184 192 2-s2.0-0028284788
77. Ng K. P., Manson J. J., Rahman A., Isenberg D. A., Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis & Rheumatism 2006 55 6 900 904 2-s2.0-33845477908 10.1002/art.22356
78. Wallace D. J., Lin H. C., Shen G. Q., Peter J. B., Antibodies to histone (H2a-H2b)-DNA complexes in the absence of antibodies to double-stranded DNA or to (Ha-H2b) complexes are more sensitive and specific for scleroderma-related disorders than for lupus. Arthritis & Rheumatism 1994 37 12 1795 1797 2-s2.0-0028170511 10.1002/art.1780371213
79. Parodi A., Drosera M., Barbieri L., Rebora A., Antihistone antibodies in scleroderma. Dermatology 1995 191 1 16 18 2-s2.0-0029038717
80. Vasoo S., Drug-induced lupus: an update. Lupus 2006 15 11 757 761 2-s2.0-39049194497 10.1177/0961203306070000
81. Rubin R. L., Drug-induced lupus. Toxicology 2005 209 2 135 147 2-s2.0-17644414511 10.1016/j.tox.2004.12.025
82. Minota S., Yoshio T., Iwamoto M., Takeda A., Masuyama J.-I., Mimori A., Yamada A., Kano S., Selective accumulation of anti-histone antibodies in glomeruli of lupus-prone Ipr mice. Clinical Immunology and Immunopathology 1996 80 1 82 87 2-s2.0-0030200542 10.1006/clin.1996.0097
83. Sui M., Lin Q., Xu Z., Han X., Xie R., Jia X., Guo X., Zhang X Guan W., Ren H., Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis. Journal of Clinical Immunology 2013 33 2 378 387
84. Reichlin M., Significance of the Ro antigen system. Journal of Clinical Immunology 1986 6 5 339 348 2-s2.0-0023024922
85. Furukawa F., Kashihara-Sawami M., Lyons M. B., Norris D. A., Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. Journal of Investigative Dermatology 1990 94 1 77 85 2-s2.0-0025139120
86. Golan T. D., Elkon K. B., Gharavi A. E., Krueger J. G., Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. The Journal of Clinical Investigation 1992 90 3 1067 1076 2-s2.0-0026779275
87. Alexander E., Buyon J. P., Provost T. T., Guarnieri T., Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model: in vitro electrophysiologic and immunocytochemical studies. Arthritis & Rheumatism 1992 35 2 176 189 2-s2.0-0026588912
88. Cimaz R., Spence D. L., Hornberger L., Silverman E. D., Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-ro autoantibodies. Journal of Pediatrics 2003 142 6 678 683 2-s2.0-0038132924 10.1067/mpd.2003.233
89. Jaeggi E., Laskin C., Hamilton R., Kingdom J., Silverman E., The importance of the level of maternal Anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus. A prospective study of 186 antibody-exposed fetuses and infants. Journal of the American College of Cardiology 2010 55 24 2778 2784 2-s2.0-77953101173 10.1016/j.jacc.2010.02.042
90. Mond C. B., Peterson M. G. E., Rothfield N. F., Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis & Rheumatism 1989 32 2 202 204 2-s2.0-0024501514
91. McCauliffe D. P., Cutaneous diseases in adults associated with Anti-Ro/SS-A autoantibody production. Lupus 1997 6 2 158 166 2-s2.0-0031047206
92. Fukuda M. V., Lo S. C., de Almeida C. S., Shinjo S. K., Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosus. Clinical Rheumatology 2009 28 3 301 304 2-s2.0-59749100026 10.1007/s10067-008-1043-5
93. Praprotnik S., Bozic B., Kveder T., Rozman B., Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjogren's syndrome: a prospective study. Clinical and Experimental Rheumatology 1999 17 1 63 68 2-s2.0-0032984338
94. Scopelitis E., Biundo J. J. Jr., Alspaugh M. A., Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis & Rheumatism 1980 23 3 287 293 2-s2.0-0018899744
95. Derksen R. H. W. M., Meilof J. F., Anti-Ro/SS-A and anti-La/SS-B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block: a longitudinal study comprising two consecutive pregnancies in a patient with systemic lupus erythematosus. Arthritis & Rheumatism 1992 35 8 953 959 2-s2.0-0026639127 10.1002/art.1780350817
96. Wahren M., Tengnér P., Gunnarsson I., Lundberg I., Hedfors E., Ringertz N. R., Pettersson I., Ro/SS-A and La/SS-B antibody level variation in patients with Sjogren's syndrome and systemic lupus erythematosus. The Journal of Autoimmunity 1998 11 1 29 38 2-s2.0-0031914069 10.1006/jaut.1997.0173
97. Hassan A. B., Lundberg I. E., Isenberg D., Wahren-Herlenius M., Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus. Scandinavian Journal of Rheumatology 2002 31 3 133 139 2-s2.0-0036290012
98. Menendez A., Gomez J., Escanlar E., Caminal-Montero L., Mozo L., Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: diagnostic utility of their separate detection. Autoimmunity 2013 46 1 32 39
99. Costedoat-Chalumeau N., Amoura Z., Villain E., Cohen L., Piette J.-C., Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Research & Therapy 2005 7 2 69 73 2-s2.0-15944397264 10.1186/ar1690
100. van Venrooij W. J., Slobbe R. L., Pruijn G. J. M., Structure and function of La and Ro RNPs. Molecular Biology Reports 1993 18 2 113 119 2-s2.0-0027652231 10.1007/BF00986765
101. Harley J. B., Autoantibodies in Sjögren's syndrome. The Journal of Autoimmunity 1989 2 4 383 394 2-s2.0-0024710305
102. Elkon K., Skelly S., Parnassa A., Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America 1986 83 19 7419 7423 2-s2.0-1842361902
103. Briani C., Lucchetta M., Ghirardello A., Toffanin E., Zampieri S., Ruggero S., Scarlato M., Quattrini A., Bassi N., Ermani M., Battistin L., Doria A., Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. The Journal of Autoimmunity 2009 32 2 79 84 2-s2.0-62149120633 10.1016/j.jaut.2008.12.002
104. Mahler M., Kessenbrock K., Szmyrka M., Takasaki Y., Garcia-De La Torre I., Shoenfeld Y., Hiepe F., Shun-Le C., Von Mühlen C. A., Locht H., Höpfl P., Wiik A., Reeves W., Fritzler M. J., International multicenter evaluation of autoantibodies to ribosomal P proteins. Clinical and Vaccine Immunology 2006 13 1 77 83 2-s2.0-33645122772 10.1128/CVI.13.1.77-83.2006
105. Toubi E., Shoenfeld Y., Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmunity Reviews 2007 6 3 119 125 2-s2.0-33846787131 10.1016/j.autrev.2006.07.004
106. Katzav A., Solodeev I., Brodsky O., Chapman J., Pick C. G., Blank M., Zhang W., Reichlin M., Shoenfeld Y., Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis & Rheumatism 2007 56 3 938 948 2-s2.0-33947175115 10.1002/art.22419
107. Matus S., Burgos P. V., Bravo-Zehnder M., Kraft R., Porras O. H., Farías P., Barros L. F., Torrealba F., Massardo L., Jacobelli S., González A., Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. The Journal of Experimental Medicine 2007 204 13 3221 3234 2-s2.0-37549017081 10.1084/jem.20071285
108. Caponi L., Anzilotti C., Longombardo G., Migliorini P., Antibodies directed against ribosomal P proteins cross-react with phospholipids. Clinical & Experimental Immunology 2007 150 1 140 143 2-s2.0-34548523701 10.1111/j.1365-2249.2007.03466.x
109. Karassa F. B., Afeltra A., Ambrozic A., Chang D.-M., De Keyser F., Doria A., Galeazzi M., Hirohata S., Hoffman I. E. A., Inanc M., Massardo L., Mathieu A., Mok C. C., Morozzi G., Sanna G., Spindler A. J., Tzioufas A. G., Yoshio T., Ioannidis J. P. A., Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis & Rheumatism 2006 54 1 312 324 2-s2.0-31044445706 10.1002/art.21539
110. Wasserman V. A., Niesser A., Bruck C., Eine sierdiagnostische Reaction bei Syphilis. Deutsche Medizinische Wochenschrift 1906 19 745 776
111. Pangbor M. D., A new serologically active phospholipid from beef heart. Proceedings of the Society for Experimental Biology and Medicine 1941 48 484 486
112. Conley C. L., Hartmann R. C., A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. The Journal of Clinical Investigation 1952 31 621 623
113. Feinstein D. I., Rapaport S. I., Acquired inhibitors of blood coagulation. Progress in Hemostasis and Thrombosis 1972 1 75 95 2-s2.0-0015458044
114. Hunt J. E., McNeil H. P., Morgan G. J., Crameri R. M., Krilis S. A., A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992 1 2 75 81 2-s2.0-0026817042
115. Reid K. B. M., C1q. Methods in Enzymology 1982 82 319 324 2-s2.0-0020010784 10.1016/0076-6879(82)82069-7
116. Bigler C., Schaller M., Perahud I., Osthoff M., Trendelenburg M., Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. Journal of Immunology 2009 183 5 3512 3521 2-s2.0-70349238894 10.4049/jimmunol.0803573
117. Holers V. M., Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus. The Journal of Clinical Investigation 2004 114 5 616 619 2-s2.0-4944254502 10.1172/JCI200422820
118. Moroni G., Trendelenburg M., Del Papa N., Quaglini S., Raschi E., Panzeri P., Testoni C., Tincani A., Banfi G., Balestrieri G., Schifferli J. A., Meroni P. L., Ponticelli C., Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. American Journal of Kidney Diseases 2001 37 3 490 498 2-s2.0-0035123526
119. Seelen M. A., Trouw L. A., Daha M. R., Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Current Opinion in Nephrology and Hypertension 2003 12 6 619 624 2-s2.0-0442292073 10.1097/00041552-200311000-00008
120. Kallenberg C. G. M., Anti-C1q autoantibodies. Autoimmunity Reviews 2008 7 8 612 615 2-s2.0-51749117999 10.1016/j.autrev.2008.06.006
121. Keith M. P., Moratz C., Tsokos G. C., Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease. Autoimmunity Reviews 2007 6 4 232 236 2-s2.0-33847073675 10.1016/j.autrev.2006.08.007
122. Migliorini P., Baldini C., Rocchi V., Bombardieri S., Anti-Sm and anti-RNP antibodies. Autoimmunity 2005 38 1 47 54 2-s2.0-17144365819 10.1080/08916930400022715
123. Tokano Y., Yasuma M., Harada S., Takasaki Y., Hashimoto H., Okumura K., Hirose S., Clinical significance of IgG subclasses of anti-Sm and U1 ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease. Journal of Clinical Immunology 1991 11 6 317 325 2-s2.0-0025949231
124. Doria A., Ruffatti A., Calligaro A., Del Ross T., Ghirardello A., De Zambiasi P., Gambari P., Antiphospholipid antibodies in mixed connective tissue disease. Clinical Rheumatology 1992 11 1 48 50 2-s2.0-0026535658
125. Takahashi Y., Haga S., Ishizaka Y., Mimori A., Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases. Arthritis Research & Therapy 2010 12 3, article R86 2-s2.0-79851513938 10.1186/ar3013
126. Iaccarino L., Gatto M., Bettio S., Caso F., Rampudda M., Zen M., Ghirardello A., Punzi L., Doria A., Overlap connective tissue disease syndromes. Autoimmunity Reviews 2013 12 3 363 373
127. Amezcua-Guerra L. M., Springall R., Marquez-Velasco R., Gómez-García L., Vargas A., Bojalil R., Presence of antibodies against cyclic citrullinated peptides in patients with "rhupus": a cross-sectional study. Arthritis Research & Therapy 2006 8 5, article R144 2-s2.0-34250212643 10.1186/ar2036
128. Simón J. A., Granados J., Cabiedes J., Morales J. R., Varela J. A., Clinical and immunogenetic characterization of Mexican patients with 'rhupus'. Lupus 2002 11 5 287 292 2-s2.0-0035985665 10.1191/0961203302lu189oa